Dengue Fever News and Research

RSS

Dengue fever is a mosquito-borne tropical disease caused by the dengue virus. Symptoms typically begin three to fourteen days after infection. These may include a high fever, headache, vomiting, muscle and joint pains, and a characteristic skin rash.

Takeda brings innovative pipeline portfolio to patients for sustained revenue growth

As part of its Wave 1 Pipeline Market Opportunity Call, Takeda Pharmaceutical Company Limited provided an update on its pipeline portfolio, which has the potential to contribute significantly to revenue growth for the company over the next decade.

From Takeda 10 Dec 2020

Virginia Tech researchers awarded NIH grant to develop Zika virus vaccine

Flaviviruses -- a group of viruses transmitted by ticks or mosquitoes -- infect an estimated 400 million people annually with diseases like yellow fever, Dengue fever, West Nile virus, and, most recently, Zika virus.

9 Dec 2020

Increasing levels of light pollution could impact transmission of diseases through mosquitoes

Artificial light abnormally increases mosquito biting behavior at night in a species that typically prefers to bite people during the day, according to research from the University of Notre Dame that was published in The American Journal of Tropical Medicine and Hygiene.

21 Oct 2020

A possible inverse relationship between Dengue and COVID-19 in Brazil

Their study titled, “How super-spreader cities, highways, hospital bed availability, and dengue fever influenced the COVID-19 epidemic in Brazil,” was released pre-peer review on the preprint medRxiv* early this week.

24 Sep 2020

As fires and floods wreak havoc on health, new climate center seeks solutions

For the past month, record-breaking wildfires have torched millions of acres from the Mexican border well into Canada, their smoke producing air so toxic that millions of people remained indoors for days on end while many visited hospitals because of respiratory distress.

24 Sep 2020

Sub-seasonal rainfall and temperature forecasts can be used to predict dengue outbreaks

A new study demonstrates for the first time that subseasonal rainfall and temperature forecasts can be used to predict outbreaks of dengue fever by estimating mosquito abundance.

25 Aug 2020

Genetically engineered mosquitoes to be released in Florida Keys

Mosquitoes are known to be vectors or bearers of several viral and protozoal infections such as dengue, Zika, yellow fever, Chikungunya, and malaria. These infections are known to infect and even kill millions around the world each year. In order to tackle this vector-borne menace, researchers have genetically engineered mosquitoes that could replace the infection carrying species of the mosquitoes.

20 Aug 2020

Startling report suggests COVID-19 may have first appeared in 2012

Now, a report on the website Independent Science News by researchers Jonathan Latham, and Allison Wilson suggests that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes the coronavirus disease (COVID-19), may not have originated at a Wuhan wet market in 2019, but 1,000 miles away in 2012, in a Chinese mineshaft where workers fell ill with a mysterious, pneumonia-like illness after being exposed to bats.

17 Aug 2020

U.S. scientists to create coronavirus strain for human challenge trials

Now, a team of scientists in the United States plans to create a coronavirus strain that can be used for human challenge trials, a controversial type of study wherein health volunteers would be vaccinated and intentionally infected with the virus.

16 Aug 2020

New system monitors, forecasts outbreak risk of dengue, Zika and other Aedes-borne diseases

Researchers led by Columbia University's International Research Institute for Climate and Society and the Pan-American Health Organization have developed a system to monitor and forecast the environmental suitability of transmission of Zika, dengue fever, chikungunya and other diseases carried by species of Aedes mosquitos in the U.S. and neighboring regions.

4 Aug 2020

Study explores if prior exposure to common cold viruses may affect SARS-CoV-2 severity

A study led by Charité - Universitätsmedizin Berlin and the Max Planck Institute for Molecular Genetics (MPIMG) shows that some healthy individuals possess immune cells capable of recognizing the novel coronavirus, SARS-CoV-2.

29 Jul 2020

Nix gene can help develop future mosquito control techniques

Virginia Tech researchers have proven that a single gene can convert female Aedes aegypti mosquitoes into fertile male mosquitoes and identified a gene needed for male mosquito flight.

15 Jul 2020

China reports Dengue fever after bubonic plague threat

The actively spreading coronavirus disease (COVID-19) first emerged in China in December 2019. More than six months after, the world grapples with nearly 11.8 confirmed cases of the viral infection. Now, as China slowly starts to reboot its economy and ease lockdown restrictions, two new health issues are emerging.

8 Jul 2020

Sanford Burnham Prebys announces research agreement with Lilly to identify COVID-19 antibodies

Sanford Burnham Prebys Medical Discovery Institute today announced a research agreement with Eli Lilly and Company (Lilly) to characterize Lilly's next-generation anti-SARS-CoV-2 antibodies.

29 Jun 2020

UConn researchers tackle a vexing problem in the development of vaccines

Researchers at UConn's Center of Excellence in Vaccine Research have made a breakthrough in vaccine development for a common and difficult to treat pneumonia-causing pathogen. Their research was recently published in the Nature Partner Journal - Vaccines.

17 Jun 2020

Researchers analyze data on RNA structure of tick-borne encephalitis virus

Researchers from Sechenov University together with colleagues from several Russian institutes analyzed data on the RNA structure of tick-borne encephalitis virus.

22 May 2020

Study sheds new light on the body's initial response to DENV infection

A study led by scientists at the Walter Reed Army Institute of Research sheds new light on the body's initial response to dengue virus (DENV) infection, describing the molecular diversity and specificity of the antibody response.

4 May 2020

Emergex partners with George Mason University for highly pathogenic RNA virus studies

Emergex Vaccines Holding Limited, a biotechnology company developing CD8+ priming set-point vaccines to prevent serious infectious diseases, today announced that it has entered into an agreement with the George Mason University, based in Virginia, in the United States.

22 Apr 2020

Pets have a low risk of transmitting multi-drug resistant bugs to owners, study finds

Zoonoses are diseases that are transmitted from animals to humans. About 75 percent of emerging infectious diseases are zoonoses, just like the coronavirus disease (COVID-19) that’s caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Domesticated animals such as pets can carry parasites and other pathogens to people. However, a new study suggests that pets are not a significant source of transmission to humans.

21 Apr 2020

Study clears potential barrier to controlling mosquito-borne diseases

New research from entomologists at UC Davis clears a potential obstacle to using CRISPR-Cas9 "gene drive" technology to control mosquito-borne diseases such as malaria, dengue fever, yellow fever and Zika.

17 Apr 2020